{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T05:18:27Z","timestamp":1780377507748,"version":"3.54.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T00:00:00Z","timestamp":1737936000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014476","name":"Pfizer BV","doi-asserted-by":"publisher","award":["61508593"],"award-info":[{"award-number":["61508593"]}],"id":[{"id":"10.13039\/100014476","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["101045236"],"award-info":[{"award-number":["101045236"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.elsevierhealth.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Nuclear Cardiology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.nuclcard.2025.102146","type":"journal-article","created":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T19:08:27Z","timestamp":1738609707000},"page":"102146","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Feasibility of the absolute quantification and left ventricular segmentation of cardiac sympathetic innervation in wild-type transthyretin amyloidosis cardiomyopathy with [123I]-MIBG SPECT\/CT: The I-NERVE study"],"prefix":"10.1016","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8414-958X","authenticated-orcid":false,"given":"Alwin","family":"Tubben","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7043-3336","authenticated-orcid":false,"given":"Niek H.J.","family":"Prakken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8675-8987","authenticated-orcid":false,"given":"Oleksandra V.","family":"Ivashchenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8572-9428","authenticated-orcid":false,"given":"Hendrea S.A.","family":"Tingen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8081-0641","authenticated-orcid":false,"given":"Andor W.J.M.","family":"Glaudemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6386-5499","authenticated-orcid":false,"given":"Walter","family":"Noordzij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3974-6830","authenticated-orcid":false,"given":"Hans L.A.","family":"Nienhuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9705-4413","authenticated-orcid":false,"given":"Peter","family":"van der Meer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5565-1164","authenticated-orcid":false,"given":"Riemer H.J.A.","family":"Slart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nuclcard.2025.102146_bib1","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1007\/s00259-012-2187-8","article-title":"(123)I-Labelled metaiodobenzylguanidine for the evaluation of cardiac sympathetic denervation in early stage amyloidosis","volume":"39","author":"Noordzij","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.nuclcard.2025.102146_bib2","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/s41569-019-0221-2","article-title":"The autonomic nervous system and cardiac arrhythmias: current concepts and emerging therapies","volume":"16","author":"Herring","year":"2019","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.nuclcard.2025.102146_bib3","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1093\/eurheartj\/ehx043","article-title":"Clinical characteristics of wild-type transthyretin cardiac amyloidosis: disproving myths","volume":"38","author":"Gonz\u00e1lez-L\u00f3pez","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.nuclcard.2025.102146_bib4","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1016\/j.cardfail.2022.07.046","article-title":"Electrical dyssynchrony in cardiac amyloidosis: prevalence, predictors, clinical correlates, and outcomes","volume":"28","author":"Martens","year":"2022","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.nuclcard.2025.102146_bib5","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.amjcard.2021.02.035","article-title":"Causes of cardiovascular hospitalization and death in patients with transthyretin amyloid cardiomyopathy (from the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial [ATTR-ACT])","volume":"148","author":"Miller","year":"2021","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.nuclcard.2025.102146_bib6","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1093\/ehjci\/jead030","article-title":"Monitoring tafamidis treatment with quantitative SPECT\/CT in transthyretin amyloid cardiomyopathy","volume":"24","author":"Rettl","year":"2023","journal-title":"Eur Hear J - Cardio Imag"},{"issue":"1","key":"10.1016\/j.nuclcard.2025.102146_bib7","doi-asserted-by":"crossref","first-page":"61","DOI":"10.17996\/anc.23-00002","article-title":"Three-dimensional heart segmentation and absolute quantitation of cardiac 123I-metaiodobenzylguanidine sympathetic imaging using SPECT\/CT","volume":"9","author":"Saito","year":"2023","journal-title":"Ann Nucl Cardiol"},{"key":"10.1016\/j.nuclcard.2025.102146_bib8","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1093\/eurheartj\/ehx589","article-title":"A\u00a0new staging system for cardiac transthyretin amyloidosis","volume":"39","author":"Gillmore","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.nuclcard.2025.102146_bib9","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1093\/eurheartj\/ehac259","article-title":"Characteristics and natural history of early-stage cardiac transthyretin amyloidosis","volume":"43","author":"Law","year":"2022","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.nuclcard.2025.102146_bib10","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/ejhf.2140","article-title":"Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology working group on myocardial and Pericardial diseases","volume":"23","author":"Garcia-Pavia","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.nuclcard.2025.102146_bib11","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s00259-022-05941-3","article-title":"123I-MIBG imaging in heart failure: impact of comorbidities on cardiac sympathetic innervation","volume":"50","author":"Gargiulo","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"10.1016\/j.nuclcard.2025.102146_bib12","doi-asserted-by":"crossref","first-page":"656","DOI":"10.3390\/ph15060656","article-title":"Cardiac 123I-mIBG imaging in heart failure","volume":"15","author":"Verschure","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.nuclcard.2025.102146_bib13","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12968-017-0389-8","article-title":"Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2\u2217 and extracellular volume: a consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imagi","volume":"19","author":"Messroghli","year":"2017","journal-title":"J\u00a0Cardiovasc Magn Reson"},{"issue":"4","key":"10.1016\/j.nuclcard.2025.102146_bib14","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1161\/hc0402.102975","article-title":"Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart","volume":"105","author":"Cerqueira","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.nuclcard.2025.102146_bib15","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/1532-429X-15-92","article-title":"Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement","volume":"15","author":"Moon","year":"2013","journal-title":"J\u00a0Cardiovasc Magn Reson"},{"issue":"3","key":"10.1016\/j.nuclcard.2025.102146_bib16","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1007\/s12350-017-0818-y","article-title":"Cardiac sympathetic nervous system imaging with 123I-meta-iodobenzylguanidine: Perspectives from Japan and Europe","volume":"24","author":"Nakajima","year":"2017","journal-title":"J\u00a0Nucl Cardiol"},{"key":"10.1016\/j.nuclcard.2025.102146_bib17","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1007\/s00259-010-1491-4","article-title":"Proposal for standardization of 123I-metaiodobenzylguanidine (MIBG) cardiac sympathetic imaging by the EANM cardiovascular committee and the European Council of Nuclear Cardiology","volume":"37","author":"Flotats","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"10.1016\/j.nuclcard.2025.102146_bib18","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s12350-017-1059-9","article-title":"Imaging cardiac innervation in amyloidosis","volume":"26","author":"Slart","year":"2019","journal-title":"J\u00a0Nucl Cardiol"},{"key":"10.1016\/j.nuclcard.2025.102146_bib19","article-title":"Analysis of quantitative [I-123] mIBG SPECT\/CT in a phantom and in patients with neuroblastoma EJNMMI","author":"Brady","year":"2019","journal-title":"Phys"},{"key":"10.1016\/j.nuclcard.2025.102146_bib20","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1161\/CIRCIMAGING.111.970608","article-title":"Aligning coronary anatomy and myocardial perfusion territories an algorithm for the core320 multicenter study","volume":"5","author":"Cerci","year":"2012","journal-title":"Circ Cardiovasc Imag"},{"key":"10.1016\/j.nuclcard.2025.102146_bib21","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.jcmg.2020.05.005","article-title":"Quantitative bone-avid tracer SPECT\/CT for cardiac amyloidosis: a crucial step forward","volume":"13","author":"Dorbala","year":"2020","journal-title":"JACC Cardiovasc Imag"},{"key":"10.1016\/j.nuclcard.2025.102146_bib22","doi-asserted-by":"crossref","first-page":"867","DOI":"10.2471\/BLT.07.045120","article-title":"The strengthening the reporting of observational studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"85","author":"von Elm","year":"2007","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.nuclcard.2025.102146_bib23","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1016\/j.jcmg.2019.06.023","article-title":"Myocardial amyloidosis: the exemplar interstitial disease","volume":"12","author":"Fontana","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.nuclcard.2025.102146_bib24","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.jcmg.2018.02.006","article-title":"Native T1 and extracellular volume in transthyretin amyloidosis","volume":"12","author":"Martinez-Naharro","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.nuclcard.2025.102146_bib25","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-94650-2","article-title":"CMR-based T1-mapping offers superior diagnostic value compared to longitudinal strain-based assessment of relative apical sparing in cardiac amyloidosis","volume":"11","author":"Korthals","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.nuclcard.2025.102146_bib26","doi-asserted-by":"crossref","DOI":"10.1007\/s00259-012-2187-8","article-title":"123I-Labelled metaiodobenzylguanidine for the evaluation of cardiac sympathetic denervation in early stage amyloidosis","author":"Noordzij","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.nuclcard.2025.102146_bib27","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/ejhf.2198","article-title":"Expert consensus on the monitoring of transthyretin amyloid cardiomyopathy","volume":"23","author":"Garcia-Pavia","year":"2021","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"10.1016\/j.nuclcard.2025.102146_bib28","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1080\/13506129.2020.1769059","article-title":"Cardiac sympathetic denervation in wild-type transthyretin amyloidosis","volume":"27","author":"Gimelli","year":"2020","journal-title":"Amyloid"},{"key":"10.1016\/j.nuclcard.2025.102146_bib29","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1016\/j.jcmg.2020.04.026","article-title":"Extracellular volume and global longitudinal strain both associate with outcomes but correlate minimally","volume":"13","author":"Fr\u00f6jdh","year":"2020","journal-title":"JACC Cardiovasc Imag"},{"key":"10.1016\/j.nuclcard.2025.102146_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.33425\/2832-4226\/23010","article-title":"The prevalence of coronary artery disease in amyloidosis is 23","volume":"8","author":"Sanchez","year":"2023","journal-title":"Am J Med Clin Sci"},{"key":"10.1016\/j.nuclcard.2025.102146_bib31","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.1007\/s12350-020-02091-7","article-title":"Relationship between heart rate response and cardiac innervation in patients with suspected or known coronary artery disease","volume":"28","author":"Nappi","year":"2021","journal-title":"J\u00a0Nucl Cardiol"},{"key":"10.1016\/j.nuclcard.2025.102146_bib32","doi-asserted-by":"crossref","first-page":"250","DOI":"10.2967\/jnmt.120.259168","article-title":"Accuracy assessment of SUV measurements in SPECT\/CT: a phantom study","volume":"49","author":"Halim","year":"2021","journal-title":"J\u00a0Nucl Med Technol"},{"key":"10.1016\/j.nuclcard.2025.102146_bib33","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1007\/s00259-022-06028-9","article-title":"EANM practice guideline for\u00a0quantitative SPECT-CT","volume":"50","author":"Dickson","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"20","key":"10.1016\/j.nuclcard.2025.102146_bib34","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/j.jacc.2010.01.014","article-title":"Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView myocardial imaging for risk evaluation in heart failure) study","volume":"55","author":"Jacobson","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.nuclcard.2025.102146_bib35","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.jaccao.2021.06.006","article-title":"ATTR amyloidosis: current and emerging management strategies","volume":"3","author":"Griffin","year":"2021","journal-title":"JACC CardioOncology"}],"container-title":["Journal of Nuclear Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358125000200?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358125000200?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T17:17:32Z","timestamp":1762363052000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071358125000200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":35,"alternative-id":["S1071358125000200"],"URL":"https:\/\/doi.org\/10.1016\/j.nuclcard.2025.102146","relation":{},"ISSN":["1071-3581"],"issn-type":[{"value":"1071-3581","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Feasibility of the absolute quantification and left ventricular segmentation of cardiac sympathetic innervation in wild-type transthyretin amyloidosis cardiomyopathy with [123I]-MIBG SPECT\/CT: The I-NERVE study","name":"articletitle","label":"Article Title"},{"value":"Journal of Nuclear Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nuclcard.2025.102146","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of American Society of Nuclear Cardiology.","name":"copyright","label":"Copyright"}],"article-number":"102146"}}